This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Mitsubishi Tanabe Pharma Corporation, Amgen Inc., Hoechst Japan Limited. Active years: 2000-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 263 
1 out of 2,074 
1 out of 66 
Years Active: 2000-2013
Title: The Innovative Journey of Masaharu Takigawa
Introduction
Masaharu Takigawa is a prominent inventor based in Okayama, Japan, renowned for his groundbreaking contributions in the field of regenerative medicine. With a career marked by the development of innovative solutions, he has secured a total of five patents, reflecting his commitment to advancing medical technology and improving patient outcomes.
Latest Patents
Among his latest inventions is a composition for the regenerative treatment of cartilage disease. This sophisticated formulation includes a PDE4 inhibitor as its active ingredient, combined with a biocompatible and biodegradable polymer. When formulated for local administration to the affected cartilage regions—such as through microsphere preparation—this pharmaceutical composition demonstrates exceptional effectiveness in the regenerative treatment of cartilage disorders.
Career Highlights
Masaharu Takigawa's professional journey includes significant tenure at Mitsubishi Tanabe Pharma Corporation, where he contributed to various innovative projects. His work in the pharmaceutical sector showcases his dedication to finding solutions for challenging medical conditions, particularly in regenerative treatments.
Collaborations
Throughout his career, Takigawa has collaborated with notable professionals in the field, including Takuya Tamatani and Katsunari Tezuka. These partnerships have enabled him to leverage shared expertise and push the boundaries of regenerative medicine research, fostering innovative advancements in treatment options.
Conclusion
Masaharu Takigawa's contributions to the field of regenerative medicine, underscored by his five patents, position him as a leading inventor dedicated to enhancing healthcare solutions. His latest work with PDE4 inhibitors and biodegradable polymers marks a significant step forward in the treatment of cartilage diseases, improving the lives of patients and paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile